DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Amanta Healthcare Limited — Press Release

NSE 1 hr ago·4 Nov 2026, 6:02 am

Amanta Healthcare

Amanta Healthcare Limited has announced its financial results for the second quarter and the first half of fiscal year 2027. The company submitted a formal press release to the stock exchange on November 3, 2026, detailing its performance metrics for the period.

This announcement is significant for investors as it provides an update on the company's operational health and financial trajectory. By reviewing these results, stakeholders can better assess the company's current standing and future growth prospects within the competitive healthcare sector.

Investors should monitor the upcoming earnings call for detailed commentary on the company's strategy and outlook. Keeping an eye on the company's execution of its business plan will be crucial for understanding its long-term value.